InvestorsHub Logo
Followers 0
Posts 6
Boards Moderated 0
Alias Born 07/19/2013

Re: ariadndndough post# 36156

Thursday, 10/17/2013 9:51:37 AM

Thursday, October 17, 2013 9:51:37 AM

Post# of 80490
From JP Morgan Note:

1) The majority of docs we surveyed who have used Iclusig do not expect their use to change over the next 6 - 12 months.

2) Most Physicians view Iclusig's safety profile "moderately worse" vs. Tasigna.

Not so bad at all...

Supertramp

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.